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Abstract 
CFTR belongs to a group of proteins sharing the structural motif of six transmembrane helices and a nucleotide binding domain. Unique to CFTR 
is the R domain, a charged cytoplasmic domain. Comparison of R domain sequences from ten species revealed that the N-terminal third is highly 
conserved, while the C-terminal two-thirds is poorly conserved. The R domain shows no strong sequence similarity to known proteins; however, 
14 viral pol proteins show limited similarity to fragments of the R domain. Analysis revealed a relationship between the N- and C-terminal fragments 
of the R domain and two discontinuous fragments of the pol protein. These observations upport a two-domain model for the R domain. 
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1. Introduction 
It is common to be faced with the predicted sequence 
of a gene product with only the slimmest clues as to its 
function. To obtain guidance for investigation, informa- 
tion may be obtained from the amino acid sequence. 
Alignment of the sequence from different species may 
indicate catalytically significant residues, and areas 
where structure is rigidly constrained. Searches of pro- 
tein data bases may provide functional identification of 
the protein, if another protein of sufficient sequence sim- 
ilarity has been characterized. Currently, functional 
identification, based on sequence similarity, is possible 
for only one in six newly identified amino acid sequences 
[l]. In the absence of functional identification of the gene 
product, functional domains may be identified or struc- 
tural information may be obtained on the basis of se- 
quence similarity [2]. 
The cloning of the cystic fibrosis gene, which encodes 
the cystic fibrosis transmembrane conductance regulator 
(CFTR) protein, was accomplished by genetic methods 
[3]. Although involvement in ion transport was indicated 
[4,5], the function of CFTR was unknown when the 
amino acid sequence was determined. Searches through 
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protein databases indicated that CFTR contains two nu- 
cleotide binding folds (NBF’s) [6] and twelve transmem- 
branes [7] and is related to a large super family of trans- 
porters containing these structural motifs [8]. Within this 
group, CFTR alone contains a highly charged, cytoplas- 
mic domain with little sequence similarity to other 
known proteins. This unique, regulatory or R domain of 
CFTR, is phosphorylated by PKA [9,10] and it has now 
been demonstrated that CFTR function involves a PKA 
regulatable chloride conductance [11,121. The R domain 
appears to have a role in gating the chloride channel 
which mediates this conductance [13,141. 
We have now analyzed the alignment of the R domain 
amino acid sequences from ten animal species. This anal- 
ysis and a distant relationship between the R domain and 
viral pol proteins which was discovered, suggests that the 
R domain is made up of two distinct parts. 
2. Methods, results and discussion 
2.1. R domain sequence conservation 
Alignment of the R domain amino acid sequence from 
ten animal species was performed using the SEQSEE 
program [ 151. The scoring matrix from this package em- 
phasizes amino acid substitutions that preserve second- 
ary structure. The R domain sequences of human [6], 
mouse [16], rat [17], dogfish [18], frog [19], and cow [20] 
consist of the amino acids encoded by exon 13 of CFTR 
(amino acids 591-830), while the rat, ginea pig, sheep 
and monkey [20] consist of amino acids 604 to 777. The 
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residue numbering scheme of human CFTR is used here 
E6]. 
To provide a visual representation of sequence conser- 
vation, a plot was prepared of the sequence similarity 
score as a function of the position in the alignment. The 
positions in the aligmnent were numbered from 1 to 251. 
Position numbers exceed the residue numbers in the 
human R domain (241), because of insertions in the 
shark domain and alignment gaps. To calculate the se- 
quence similarity score for each position, the residue 
from each species at that position was compared with the 
aligned human residue. An individual score for the com- 
parison was assigned with the SEQSEE scoring matrix 
[15]. This matrix gives scores for each of the possible 210 
amino acid substitutions or conservations: values of 10 
to 16 reflect conservation, values of 3 to 9 conservative 
substitution, and values of 0 to 2 non-conservative sub- 
stitution. Gaps in the alignment were scored as 0. The 
sequence similarity score for each residue position is the 
sum of the individual scores for comparison of each 
species with the human. Where sequences from only six 
species were compared, the score was multiplied by 1.8 
for normalization. Fig. 1A shows the results of this cal- 
culation. Positions of low sequence similarity are likely 
to represent urns or external oops in the R domain. It 
is clear that approximately the first 80 amino acids are 
highly conserved, showing 64% identity. The next 140 
amino acids are less well conserved with 23% identity. 
The final 20 residues in the alignment are 68% identical. 
Gaps in the alignment are notable at positions 83 and 
225. 
2.2. Two domain model of the R domain 
The R domain was o~ginally defined as exon 13 of 
CFTR [6], However, the high sequence similarity at the 
bo~daries of exon 13 suggests protein domain bounda- 
ries may not coincide. To postulate domain boundaries, 
previously recognized domains of CFTR were included. 
The first NBF, as defined by alignment with other 
known NBF’s, ends three residues prior to the beginning 
of the exon 13 coding sequence. Twenty-nine amino 
acids are predicted between the end of exon 13 coding 
sequence and the seventh transmembrane domain. The 
sequence similarity pattern of the R domain suggests two 
discrete domains. Differences in the degree of conserva- 
tion in separate functional domains of a single polypep- 
tide chain has been observed in other proteins [21]. We 
postulate, RDl, the first domain within the R domain to 
extend from amino acids 587 to 672 of CFTR. High 
homology in this domain suggests that the structural 
constraints are rigid. RD2, the C-terminal domain of the 
R domain, with less rigid structural requirements, ex- 
tends from amino acids 679 to 798 of CFTR. The gap 
in the sequence alignment at position 225 and the abrupt 
change in conservation suggest hat amino acid 806 of 
CFTR is the beginning of the RTM region, which links 
the R domain and the seventh transmembrane domain, 
Fig. 1B shows an R domain alig~ent with all domain 
boundaries highlighted. 
2.3. Conservation ofphosphorylation sites 
Phospho~lation of CFTR by PKA mediates protein 
function. Phosphorylation by PKC also has a role in 
controlling protein function, but it is subtle and less 
clearly understood [22,23]. Most of the predicted PKA 
and PKC phosphorylation sites in the R domain fall in 
RD2 where the primary sequence is not well conserved, 
as shown in Fig. 1A. However, 8 of the PKA sites are 
highly conserved: amino acids 660, 686, 700, 712, 737, 
768, 795 and 813 in CFTR. The site at residue 196 
(amino acid 788) is found only in human. Similarly, most 
of the PKC sites are well conserved, with the exception 
of the site at amino acid 791. Although the C-terminal 
domain of the R domain is itself not well conserved, 
many of the phosphorylation sites are, suggesting that 
while the structural requirements on the domain are not 
stringent, phosphorylation of the domain is important 
for CFTR function, 
2.4. Low sequence similarity between the R domain and 
pal proteins 
At the time of the cloning of CFTR, no other proteins 
or protein domains were identified that were highly sim- 
ilar to the R domain [6]. This finding still holds. How- 
ever, it is stricking that a low level of similarity exists 
between various segments of the R domain and 14 difler- 
ent viral pol (polymerase) proteins (Fig. 2), as revealed 
in searches of the Protein Resource Information (PIR) 
database (National Biomedical Resource Foundation, 
Washington, DC). The FASTA algorithm [24] identified 
seven retroviral pol proteins showing sequence similarity 
to the R domain. Seven pol proteins from a heterogene- 
ous group of RNA genome viruses also show limited 
sequence similarity to the R domain. These pol proteins 
have been described as RNA polymerase activities, and 
the reverse transcriptase domain of the retroviral pol 
protein was originally defined by sequence similarity to 
the E. coli RNA polymerase u subunit 2393. 
2.5. ~~g~~~cu~ce o a~i~~rnent between R do~in and pof 
proteins 
The similarity between the R domain and pol proteins 
falls into a statistically wooly area. The alignment of the 
R domain with each of the 14 viral proteins scored be- 
tween 3.3 and 7.8 standard deviations from the mean. 
Scores between three and six standard deviations above 
the mean are considered to be equally consistent with 
either two distantly related sequences or two sequences 
which are unrelated and align by chance [40]. Monte 
Carlo analysis was performed to address the possibility 
of common bias in amino acid usage but proved incon- 
clusive 1411. Sander and Schneider have demonstrated 
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Fig. 1. Amino acid sequence conservation in the R domain. (A) Amino acid sequences from ten animal species were aligned using the SEQSEE 
algorithm. Each position in the alignment was given a mnnerical score based on the degree of conservation. Alignment position 1 corresponds to 
residue 590 in human CPTR and position 251 to residue 830. The fractional conservation of the putative phosphorylation sites by PKA and PKC 
are also indicated. (3) Sequence ~~rnent of R domain from six species, indicating proposed domain boundaries. Abbreviations: RDI, 1st R domain 
domain; RD2,Znd R domain domain; RTM, domain linking R domain and transmembrane 7; TM7, transmembrane domain 7. 
that the longer the length of the alig~ent of two se- 
quences, the lower the identity between the sequences 
needs to be for the two proteins to be related structurally 
1421. This trend suggests that the R domain may be re- 
lated to the pol proteins, and the relationship warranted 
further investigation. 
It was considered that if there exists any biologically 
relevant sequence similarity between the viral pol pro- 
teins and the R domain, the same part of the R domain 
should align with the same functional part of the viral pol 
protein, The functional parts of the various pol proteins 
are not immediately obvious, as the various proteins 
contain different enzymatic activities. To provide func- 
tional identity of the residues in the pol proteins, each 
was aligned with the Moloney murine leukemia virus 
(MMLV) pol protein [43]. Since the common character- 
istic of the 14 pol proteins with putative relationship to 
the R domain is their similarity to RNA pofymerase 
activities, an RNA polymerase might have been chosen 
as a functional reference. However, the MMLV pol was 
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Fig. 2. Alignment of the R domain with viral pal proteins. The R domain sequence is in the center in capital etters and the viral sequences are aligned 
around it. Where the viral sequence shows exact conservation, the viral residue is capitalized. The table indicates features of each aligned viral 
sequence. s.d., standard deviations from mean score obtained searching the database. 
chosen because: more of the pal proteins were retroviral, 
alignments for some of the pol proteins with the MMLV 
were available in the literature and could be used to 
confirm the alignments performed here, there is consid- 
erable information available about the structure/func- 
tion of the MMLV pol protein and some of the aligned 
fragments from the retroviral proteins might code for 
non-polymerse activities. 
The alignments of the 14 viral pal sequences with the 
MMLV pol obtained with the SEQSEE algorithm 
agreed with those reported in the literature [21,25,26&l]. 
Insufficient information is available for a rigorous evalu- 
ation of the goodness of the alignment. However, if the 
alignments are inaccurate, they will not be expected to 
cont~bute false positive conclusions in this study. Con- 
sidering that, ignoring gaps, there are 2100 (approximate 
sum of the lengths of the MMLV pol protein and the 
other viral po1 protein) possible alignments of a viral 
protein with MMLV pol. There are 13 other potential 
alignments of the R domain with the MMLV pol se- 
quence, from each of the other viral proteins. It would 
be expected that an incorrect ali~ment of a viral protein 
would then coincide with one of the other 13 alignments 
by chance at a frequency of 13/2100 = 0.006. Gaps are 
ignored here for simplicity; if gaps are included, there are 
more possible alignments, and the outcome becomes 
more unlikely as a result of chance. 
The sequence similarity score from the alignment of 
each viral pol protein with the R domain was calculated 
using the SEQSEE scoring matrix. The fragment of the 
viral sequence identified using the FASTA algorithm 
was compared to the alignment of the ten R domain 
sequences. The value assigned for the sequence similarity 
at any position was the sum of the conservation scores 
from the SEQSEE matrix obtained by comparing the 
residue in the viral sequence to the R domain residue 
from each species in R domain sequence alignment. 
Where the same R domain residue aligned with the same 
MMLV pol protein residue in more than one viral pro- 
tein, the sequence similarity score was taken as the sum 
of all the scores at that position. 
The sequence similarity score was plotted as a function 
of the residue number in the R domain and the residue 
number of the MMLV pol protein to which each of the 
viral sequences was aligned. Fig. 3A contains this plot. 
Significance of alignment of the R domain and the 
MMLV pol protein mapping was judged on two proper- 
ties of the plot: the position of the lines in the R domain 
residue-p01 protein residue plane and the ma~itude of 
the sequence similarity score. 
If the ali~ments have biological relevance, then the 
same fragment of the R domain should align with the 
same Functional part of the pol protein. Amidst a back- 
ground of noise, there is ‘constructive interference’ in the 
Fig. 3A. Constructive interference is indicated by areas 
on the plot where the lines are more intense (generally 
blacker) and higher, as a result of the coincidence of 
more than one data set and high sequence similarity 
Fig. 3. Sequence similarity between the R domain and 14 viral pal proteins. The degree of sequence similarity was calculated for each alignment of 
the R domain and the viral protein, and then plotted as a function of the residue number in the R domain and the residue number of the MMLV 
pal protein to which the virat sequence was mapped. The type of virus from which each line originated is indicated on the graph. (A) Sequence similarity 
scores are shown starting from a value of zero. (B) The threshold for sequence similarity has been raised to a value of 150, deemed to represent 
conservative substitution. 
score. R domain residues 15 to 70 align with equivalent 
pol protein residues 245-300 in HIV, SIV, visna and the 
N-terminal fragment of the rotaviruses. Similarly, con- 
structive interference is observed in the alignment of R 
domain residues W-1.50 and the MMLV pol protein 
residues 490 to 560 in the foamy and C-terminal frag- 
ment of the rotaviruses. It is particularly interesting that 
the aligmnent of the rotaviruses constructively interfere 
with those of the retroviruses. The rotaviruses and retro- 
viruses are not generally consider to be related. How- 
ever, the likelihood of the rotavirus alignments coincid- 
ing with the retroviral alignments of the R domain, par- 
ticularly in two disjunct sequences by chance is low and 
is likely biologically relevant. Sequences which lack con- 
structive interference, such as the Dengue, yellow fever, 
pea mosaic, and potato cannot be called significant by 
this analysis. 
The magnitude of the sequence similarity was also 
considered. A score of 150 was deemed to signify conser- 
vative substitution and the similarity scores were plotted 
with this threshold, as shown in Fig. 3B. It is evident that 
the sequence alignment of the R domain at residues 15- 
70 shows higher similarity to pol residues 245-300 than 
to pol residues around 400 to 450. Similarly, the se- 
quence simila~ty provided by the gibbon ape leukemia 
and simian sarcoma protein alignments around pol resi- 
dues 1000 to 1030 are less significant han those around 
500. Therefore, it appears that the R domain is related 
to the viral pol protein, with the R domain residues 
15-70 and 80-150 related to, respectively, pol protein 
residues 245 to 300 and 490-560, in the residue number- 
ing scheme of the MMLV pol protein. 
The reiationship between the R domain and the viral 
pol proteins supports the two domain model for the R 
domain. The proposed RDl domain is related to part of 
the pol protein which is not contiguous with the part of 
the pol protein to which the proposed RD2 domain ap- 
pears to be related. The existence of two domains within 
the R domain is supported by data describing the func- 
tion of CFTR with deletions in the R domain (453. Based 
on ‘functional domains’, the boundary between the first 
and second domain has been postulated to be at amino 
acid 708. It is easy to envision that to maintain a func- 
tional molecule with an internal domain deleted, a few 
amino acids from the deleted domain may be required 
to keep the remainder of the molecule in the correct 
spatial orientation. This may explain the discrepancy 
between the boundaries presented here and those pro- 
posed in [45]. 
A functions relationship between the R domain and 
the pol proteins is unlikely based on what is known of 
the functions of CFTR and the pol proteins. Thus, it is 
likely that the pol proteins and R domain share some 
three-~mension~ characteristics in areas where the se- 
quences are related. There exists precedent for proteins 
which show low sequence similarity and little functional 
similarity but structural relationships [2,46]. The MMLV 
residues 245 to 300 are located in the retroviral reverse 
transcriptase between the nucleotide binding site and the 
catalytic center [47]. MMLV residues 490-560 are lo- 
cated in what has been called the tether [39] region of the 
retroviral pol protein between the reverse transciptase 
114 A.M. Dulhanty, J.R RiordanlFEBS Letters 343 (1994) 109-114 
and the RNaseH. At present, there is no three-dimen- 
sional structural data available for pol proteins; how- 
ever, when it becomes available it may provide insight 
into the structure of the R domain. 
Analysis of the amino acid sequence of the R domain 
of CFTR has suggested that it may in fact be composed 
of two domains. This finding should further the knowl- 
edge of the structure/function relationship of CFTR. 
Acknowledgements: We would like to thank J. Forman-Kay for her 
helpful comments on the manuscript and P. Romkey for his technical 
assistance. A.M.D. is a recipient of an MRC-ICI Pharma fellowship. 
This work was supported by grants from the US and Canadian Cystic 
Fibrosis Foundations and the NIH-NIDDK. 
[l] Rost, B., Schneider, R. and Sander, C. (1993)Trends Biocbem. Sci. 
18, 12@123. 
[2] Bajorath, J., Stenkamp, R. and Aruffo, A. (1993) Protein Sci. 2, 
1798-1810. 
[3] Rommens, J., Iannuzzi, M., Kerem, B.-S., Drumm, M., Melmer, 
G., Dean, M., Rozmahel, R., Cole, J., Kennedy, D., Hidaka, N., 
Zsiga, M., Buchwald, M., Riordan, J., Tsui, L.-C. and Collins, F. 
(1989) Science 245, 1059-1065. 
[4] Quinton, P. (1983) Nature 301, 421422. 
[5] Welsh, M. and Liedtke, C. (1986) Nature 322,467-470. 
[6] Riordan, J., Rommens, J., Kerem, B.-S., Alon, N., Rozmabel, R., 
Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., 
Drumm, M., Iannuzzi, M., Collins, F. and Tsui, L.-C. (1989) 
Science 245, 1066-1073. 
[A Eisenburg, D. (1984) Annu. Rev. B&hem. 53, 595-623. 
[S] Higgins, C. (1992) Annu. Rev. Cell Bid. 8, 67-113. 
[9] Cheng, S., Rich, D., Marshall, J., Gregory, R., Welsh, M. and 
Smith, A. (1991) Cell 66, 1027-1036. 
[IO] Picciotto, M., Cohn, J., Bertuzzi, G., Greengard, P. and Nairn, A. 
(1992) J. Biol. Chem. 267, 12742-12752. 
[1 11 Bear, C., Li, C, Kartner, N., Bridges, R., Jensen, T., Ramjeesingh, 
M. and Riordan, J. (1992) Cell 68, 809-818. 
[12] Rich, D., Anderson, M., Gregory, R., Cheng, S., Paul, S., Jeffer- 
son, D., McCann, J., Klinger, K., Smith, A. and Weish, M. (1990) 
Nature 347, 358-363. 
[13] Rich, D., Gregory, R., Anderson, M., Manavalan, P., Smith, A. 
and Welsh, M. (1991) Science 253,205-207. 
[14] Chang, X.-B., Tabcharani, J., Hou, Y.-X., Jensen, T., Kartner, N., 
Alon, N., Hanrahan, J. and Riordan, J. (1993) J. Biol. Chem. 268, 
11304-11311. 
[lS] Wishart, D., Boyko, R., Willard, L., Richards, E and Sykes, B. 
(1994) CABIOS, in press. 
[16] Tata, F. Stanier, P., Wickling, C., Halford, S., Kruyer, H., Lench, 
N., Scambler, P., Hansen, C., Braman, J., Williamson, R. and 
Wainwri8ht, B. (1991) Genomics 10, 301-307. 
[l?] Trezise, A., Szpirer, C. and Buchwald, M. (1992) Genomics 14, 
869-874. 
[18] Marshall, J., Martin, K., Picciotto, M., Ho&field, S., Nairn, A. 
and Kaczmarek, L. (1991) J. Biol. Chem. 266,22749-22754. 
[19] Tucker, S., Tannahill, D. and Higgins, C. (1992) Hum. Mol. 
Genet. 1, 77-82. 
[20] Diamond, G., Scanlin, T., Zasloff, M. and Bevins, C. (1991) 
J. Biol. Chem. 266, 22761-22769. 
1211 Doolittle, R., Feng, D.-F., Johnson, M. and McClure, M. (1989) 
Q, Rev. Biol. 64, I-30. 
[22] Tabcharani, J., Chang, X.-B., Riordan, J. and Hanrahan, J. (1991) 
Nature 352, 628631. 
[23] Berger, H., Travis, S. and Welsh, M. (1993) J. Biol. Chem. 268, 
2037-2047. 
[24] Pearson, W. and Lipman, D. (1988) Proc. Natl. Acad. Sci. USA 
85,24442448. 
[25] Sonigo, P., Alizon, M., Staskus, K., Klatzmann, D., Cole, S., 
Danos, O., Retzel, E., Tiolain, I?, Haase, A. and Wain-Hobson, 
S. (1985) Cell 42, 369-382. 
[26] Maurer, B., Bannert, H., Daral, G. and Flugel, R. (1988) J. Virol. 
62, 1590-1597. 
[27] Renne, R., Friedl, E., Schweizer, M., Fleps, U., Turek, R. and 
Ne~ann-Haefeliu, D. (1992) Virology 186, 597-608. 
[2S] Chakrabarti, L., Guyader, M., Alizon, M., Daniel, M., Desrosiers, 
R., Tiollais, P. and Sonigo, P. (1987) Nature 328, 543-547. 
[29] Spire, B., Sire, J., Sachar, V., Rey, F., Barre-Sinoussi, F., Galibert, 
E, Hampe, A. and Chermann, J. (1989) Gene 81,275-284. 
[30] Delassus, S., Sonigo, P. and Wain-Hobson, S. (1989) Virology 173, 
205-213. 
[31] Devare, S., Reddy, E., Law, J., Robbins, K. and Aaronson, S. 
(1983) Proc. Natl. Acad. Sci. USA 80,731-735. 
1321 Robaglia, C. , Durand-Tardif, M., Tronchet, M., Boudazin, G., 
Astier-Manifacier, S. and Casse-Delbart, F. (1989) J. Gen. Virol. 
70, 935-947. 
[33] Johansen, E., Rasmussen, O., Heide, M. and Borkhardt, B. (1991) 
J. Gen. Viral. 72, 2625-2632. 
[34] Hahn, Y., Caller, R., Hunkapiller, T., Dalrymple, J., Strauss, J. 
and Strauss, E. (1988) Virology 162, 167-180. 
[3S] Rice, C., Lenches, E., Eddy, S., Shin, S.J., Sheets, R. and Strauss, 
J. (1985) Science 229, 726733. 
[36] Fukuhara, N., Nishikawa, K., Gorziglia, M. and Kapikian, A. 
(1989) Virology 173, 743-749. 
[37] Mitchell, D. and Both, G. (1990) Virology 177, 324-331. 
[38] Cohen, J., Charpilienne, A., Chilmon~yk, S. and Estes, M. (1989) 
Virology 171, 131-140. 
[39] Johnson, M., McClure, M., Feng, D.-F., Gray, J. and Doolittle, 
R. (1986) Proc. Natl. Acad. Sci. USA 83, ‘76487652. 
[40] Pearson, W. (1990) Methods Enzymol. 183, 63-98. 
[41] Doolittle, R. (1981) Science 214, 149-159. 
1421 Sander, C. and Schneider, R. (1991) Proteins 9, 56-68. 
[43] Shinnick, T., Lerner, R. and Sutcliffe, G. (1981) Nature 293, 543- 
548. 
1441 Toh, H., Hayashida, H. and Miyata, T. (1983) Nature 305, 827- 
829. 
[45] Rich, D., Gregory, R., Cheng, S., Smith, A. and Welch, M. (1993) 
1, 221-232. 
1461 Flores, T., Orengo, C., Moss, D. and Thornton, J. (1993) Protein 
Sci. 2, 1811-1826. 
[471 Lewe, G. and Flugel, R. (1990) Virus Genes 3, I95-204. 
